Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial

von Seidlein L., Peto TJ., Landier J., Nguyen T-N., Tripura R., Phommasone K., Pongvongsa T., Lwin KM., Keereecharoen L., Kajeechiwa L., Thwin MM., Parker DM., Wiladphaingern J., Nosten S., Proux S., Corbel V., Tuong-Vy N., Phuc-Nhi TL., Son DH., Huong-Thu PN., Tuyen NTK., Tien NT., Dong LT., Hue DV., Quang HH., Nguon C., Davoeung C., Rekol H., Adhikari B., Henriques G., Phongmany P., Suangkanarat P., Jeeyapant A., Vihokhern B., van der Pluijm RW., Lubell Y., White LJ., Aguas R., Promnarate C., Sirithiranont P., Malleret B., Rénia L., Onsjö C., Chan XH., Chalk J., Miotto O., Patumrat K., Chotivanich K., Hanboonkunupakarn B., Jittmala P., Kaehler N., Cheah PY., Pell C., Dhorda M., Imwong M., Snounou G., Mukaka M., Peerawaranun P., Lee SJ., Simpson JA., Pukrittayakamee S., Singhasivanon P., Grobusch MP., Cobelens F., Smithuis F., Newton PN., Thwaites GE., Day NPJ., Mayxay M., Hien TT., Nosten FH., Dondorp AM., White NJ.